Bektur, C.; Kayir, F.; Nurgozhin, T.
(Value in Health, 2014-11-01)
The purpose of present study was to evaluate the cost-effectiveness of tocilizumab (TCZ) vs. infliximab (IFX) for the treatment of patients with rheumatoid arthritis (RA) from the perspective of Ministry of Health (MoH) ...